Difference between revisions of "Part:BBa K404210"
(→Usage and Biology) |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K404210 short</partinfo> | <partinfo>BBa_K404210 short</partinfo> | ||
+ | {| style="color:black" cellpadding="6" cellspacing="1" border="2" align="left" | ||
+ | ! colspan="2" style="background:#66bbff;"|[https://parts.igem.org/Part:BBa_K404210 ViralBrick-587KO-Empty] | ||
+ | |- | ||
+ | |'''BioBrick Nr.''' | ||
+ | |[https://parts.igem.org/Part:BBa_K404210 BBa_K404210] | ||
+ | |- | ||
+ | |'''RFC standard''' | ||
+ | |[https://parts.igem.org/Help:Assembly_standard_25 RFC 25] | ||
+ | |- | ||
+ | |'''Requirement''' | ||
+ | |pSB1C3<br> | ||
+ | |- | ||
+ | |'''Source''' | ||
+ | | | ||
+ | |- | ||
+ | |'''Submitted by''' | ||
+ | |[http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010] | ||
+ | |} | ||
+ | <br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/> | ||
[[Image:Freiburg10_ViralBrick-logo-587KO-empty.png|thumb|center|480px]]<br> | [[Image:Freiburg10_ViralBrick-logo-587KO-empty.png|thumb|center|480px]]<br> | ||
Line 19: | Line 38: | ||
− | ===Restriction sites | + | ===Restriction sites=== |
<table border="1" style="float:right; width:480px; height:auto;> | <table border="1" style="float:right; width:480px; height:auto;> | ||
<tr> | <tr> |
Latest revision as of 02:41, 28 October 2010
ViralBrick-587KO-Empty
ViralBrick-587KO-Empty | |
---|---|
BioBrick Nr. | BBa_K404210 |
RFC standard | RFC 25 |
Requirement | pSB1C3 |
Source | |
Submitted by | [http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010] |
Usage and Biology
The primary receptor of AAV-2 is the heparan sulfate proteoglycan (HSPG) receptor (Perabo et al. 2006). Its binding motif consists of five amino-acids located on the capsid surface: R484/R487, K532, R585/587. (Trepel et al. 2009).
The positively charged arginine residues interact with the HSPGs' negatively charged acid residues. Opie et al. have shown that two point mutations (R585A and R588A) are sufficient to eliminate the heparin binding affinity in AAV2.
(Opie et al. 2003). This ViralBrick has been created to introduce this knockout into other constructs. The biobricks with containing this knockout are annotated with „HSPG-ko“.
Restriction sites
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 10
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]